Germany To Ban Export Of Ozempic Weight Loss Drug

Editorial Illustration Novo Nordisk Ozempic Poland Polska Warsaw Warszawa box brand branding care diabetes diabetes management diabetes treatment dosage drop drug health healthcare injection insulin insulin analog lifestyle loss marketing medical device medication medicine metabolic health needle needle pen obesity package packaging patient care pen pharma pharmaceutical self-administration shot therapy weight weight loss wellness. Ozempic weight loss drug packaging illustration Novo Nordisk Warsaw Poland 19 November 2023 German regulator BfArM export ban manufacturing Danish company shortages popularity United States prescription diabetes risk of diabetes stand alone weight loss solution Jaap Arriens NurPhoto medication health care pharmaceutical industry treatment regulatory authority international trade medical supply chronic disease management obesity therapeutic use healthcare policy market demand supply chain issues